Brief: Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Myriad Genetics

18/01/2024 23:12

Jan 18 (Reuters) - Myriad Genetics Inc  MYGN.O :
    * MYRIAD GENETICS TO ACQUIRE PRECISE TUMOR, PRECISE LIQUID
AND
LABORATORY FROM INTERMOUNTAIN PRECISION GENOMICS
    * MYRIAD GENETICS INC: FINANCIAL TERMS OF DEAL WERE NOT
DISCLOSED
BUT ARE NOT MATERIAL TO EITHER MYRIAD OR INTERMOUNTAIN
HEALTHCARE
    * MYRIAD GENETICS INC - UPON CLOSING OF ACQUISITION ON
FEBRUARY 1,
2024, MYRIAD EXPECTS TO OPERATE THERAMAP: SOLID TUMOR SOLELY AS
PRECISE TUMOR

Source text for Eikon:  ID:nGNX4VBlg8 
Further company coverage:  MYGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))